Dig Dis Sci 2013;58:172-8.PubMed 71
People with active or prior cancer, because GH/IGF-1 signaling is a theoretical concern
"We believe we are building the next generation healthcare platform, a platform that leverages personalization and technology unlike any traditional healthcare system, delivering access to affordable, on-demand, high-quality and precision-tailored care to millions of people, the future model of health and wellness that centers around the consumer and the consumer alone," CEO Andrew Dudum said on the call Monday
GLP-1 agonists can drive significant weight loss, but without adequate dietary protein and resistance training, you will lose vital lean muscle massa serious longevity liability
Called Byetta (exenatide) and originally developed by Amylin Pharmaceuticals, the drug was later marketed by AstraZeneca
Efficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, placebo-controlled study
